PCOS Has Been Renamed PMOS – What the Change Means for Every Woman Diagnosed With This Condition

If you’ve been diagnosed with polycystic ovary syndrome, the condition has genuinely just been renamed. On May 12, 2026, The Lancet published the result of a decade-long global consensus process — more than 50 patient and professional organizations (56 in total), including the Endocrine Society, and over 14,300 survey responses from people with the condition and healthcare professionals worldwide. The new name is Polyendocrine Metabolic Ovarian Syndrome (PMOS) — and notice that “polycystic” has been dropped entirely, which is the actual point of the change, not a footnote to it.

This isn’t cosmetic. It reflects a real shift in how the condition is understood, and it affects an estimated 1 in 8 women worldwide — more than 170 million people. In India, separate estimates suggest 20-25% of women of reproductive age have some form of the condition, making it more common than diabetes in that age group.

Why “polycystic” had to go

The original name dates to the 1930s, based on how ovaries appeared under early ultrasound — multiple small follicles that clinicians called cysts. The name stuck for decades even as research increasingly showed those follicles are arrested, not pathological, and that they’re a downstream symptom rather than the actual disease process. In the consensus survey, 86% of patients and 71% of healthcare professionals supported moving to a name that didn’t imply ovarian pathology that isn’t really there.

What the new name foregrounds instead is what the evidence has shown for years: this is primarily a metabolic and endocrine condition. In most cases, insulin resistance is the root driver — the same mechanism underlying type 2 diabetes. When cells stop responding properly to insulin, the pancreas compensates by producing more of it; the excess insulin drives the ovaries to produce more androgens, and elevated androgens disrupt ovulation, cause acne, and trigger excess hair growth. The follicles that show up on ultrasound are downstream of that cascade, not its source.

What actually changes for patients

Metabolic screening becomes a standard part of diagnosis, not an afterthought — fasting insulin, glucose, HbA1c, lipids, and blood pressure alongside the reproductive hormone panel. An ovarian ultrasound showing follicles is no longer sufficient on its own; diagnosis now requires evidence of the underlying hormonal or metabolic dysfunction. Treatment correspondingly shifts toward metabolic intervention first — diet, exercise, and insulin-sensitizing approaches — because addressing insulin resistance often resolves the downstream hormonal symptoms without targeting them directly. And the long-term disease risks that come with this condition — meaningfully higher lifetime risk of type 2 diabetes, cardiovascular disease, and endometrial cancer — get addressed from the point of diagnosis rather than treated as separate, later concerns.

What to actually do with this information

If you’ve been diagnosed with PCOS, your diagnosis still stands — only the name and the understanding of its root cause have been updated. Ask your doctor for a full metabolic panel if you haven’t had one: fasting insulin, fasting glucose, HbA1c, lipid profile, and blood pressure. Many women with this condition have significant insulin resistance that’s never been formally tested. A low-glycemic diet has strong evidence for improving symptoms, and even a modest 5-10% weight loss can restore ovulation in some women. Berberine, derived from the barberry plant, has been studied in multiple clinical trials specifically for this condition — a 2024 meta-analysis found it improved menstrual regularity, reduced androgen levels, and improved insulin sensitivity, with an effect size comparable to metformin in some studies.

Dr. Ajit Kumar’s clinical perspective

The bigger picture

The renaming reflects medicine catching up with evidence that’s been accumulating for years: this is a whole-body metabolic condition, not a reproductive quirk confined to the ovaries. It should also reduce a specific, real harm — the word “polycystic” led many women to believe their ovaries were permanently or structurally damaged, which isn’t accurate and added unnecessary anxiety on top of an already difficult diagnosis. If you or someone you know has this condition, it’s a reasonable moment to revisit the diagnosis with your doctor, ask about metabolic testing if you haven’t had it, and know that with the right approach, it’s highly manageable.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your treatment plan.